Asensus Surgical Inc (ASXC)
0.241
0.00 (0.00%)
USD |
NYAM |
May 03, 16:00
0.2457
0.00 (0.00%)
After-Hours: 20:00
Asensus Surgical Cash from Financing (Quarterly): 0.172M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.172M |
| September 30, 2023 | 9.743M |
| June 30, 2023 | 0.194M |
| March 31, 2023 | -0.483M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.001M |
| June 30, 2022 | 0.005M |
| March 31, 2022 | -0.336M |
| December 31, 2021 | 1.564M |
| September 30, 2021 | 0.033M |
| June 30, 2021 | 0.503M |
| March 31, 2021 | 159.60M |
| December 31, 2020 | 8.936M |
| September 30, 2020 | 13.65M |
| June 30, 2020 | 6.081M |
| March 31, 2020 | 24.70M |
| December 31, 2019 | -14.34M |
| September 30, 2019 | 8.73M |
| June 30, 2019 | 0.268M |
| March 31, 2019 | -0.263M |
| December 31, 2018 | 10.31M |
| September 30, 2018 | 0.156M |
| June 30, 2018 | 11.26M |
| March 31, 2018 | 4.723M |
| December 31, 2017 | 68.33M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.167M |
| June 30, 2017 | 25.54M |
| March 31, 2017 | 3.338M |
| December 31, 2016 | -2.755M |
| September 30, 2016 | -1.896M |
| June 30, 2016 | 24.54M |
| March 31, 2016 | 30.05M |
| December 31, 2015 | -0.026M |
| September 30, 2015 | 15.65M |
| June 30, 2015 | 50.80M |
| March 31, 2015 | 1.979M |
| December 31, 2014 | -0.012M |
| September 30, 2014 | 3.317M |
| June 30, 2014 | 51.56M |
| March 31, 2014 | -0.93M |
| December 31, 2013 | -0.775M |
| September 30, 2013 | 29.60M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 5.956M |
| September 30, 2012 | -1.572M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 5.843M |
| December 31, 2011 | 1.375M |
| September 30, 2011 | 1.093M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-14.34M
Minimum
Dec 2019
159.60M
Maximum
Mar 2021
11.53M
Average
0.268M
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Glaukos Corp | 13.17M |
| Perspective Therapeutics Inc | 0.352M |
| Retractable Technologies Inc | -0.1364M |
| Xtant Medical Holdings Inc | 0.325M |
| Catheter Precision Inc | -0.107M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.37M |
| Cash from Investing (Quarterly) | 7.427M |
| Free Cash Flow | -64.19M |
| Free Cash Flow Per Share (Quarterly) | -0.0508 |
| Free Cash Flow to Equity (Quarterly) | -13.45M |
| Free Cash Flow to Firm (Quarterly) | -13.45M |
| Free Cash Flow Yield | -106.7% |